Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06281964	Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion.(KANNON-2)	enrolling by invitation	Phase 3	327	Avistone Biotechnology Co., Ltd.INDUSTRY	1	Apr 23, 2026	clinicaltrials
NCT06759857	FHND9041 Versus Afatinib for Non-small Cell Lung Cancer(FHND9041)	enrolling by invitation	Phase 3	350	Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.INDUSTRY